Cargando…
Discovery of 1,2,4-Triazine Derivatives as Adenosine A(2A) Antagonists using Structure Based Drug Design
[Image: see text] Potent, ligand efficient, selective, and orally efficacious 1,2,4-triazine derivatives have been identified using structure based drug design approaches as antagonists of the adenosine A(2A) receptor. The X-ray crystal structures of compounds 4e and 4g bound to the GPCR illustrate...
Autores principales: | Congreve, Miles, Andrews, Stephen P., Doré, Andrew S., Hollenstein, Kaspar, Hurrell, Edward, Langmead, Christopher J., Mason, Jonathan S., Ng, Irene W., Tehan, Benjamin, Zhukov, Andrei, Weir, Malcolm, Marshall, Fiona H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2012
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3308197/ https://www.ncbi.nlm.nih.gov/pubmed/22220592 http://dx.doi.org/10.1021/jm201376w |
Ejemplares similares
-
Identification of Novel
Adenosine A(2A) Receptor
Antagonists by Virtual Screening
por: Langmead, Christopher J., et al.
Publicado: (2012) -
Biophysical Mapping of the Adenosine A(2A) Receptor
por: Zhukov, Andrei, et al.
Publicado: (2011) -
X‐Ray Crystallography and Free Energy Calculations Reveal the Binding Mechanism of A(2A) Adenosine Receptor Antagonists
por: Jespers, Willem, et al.
Publicado: (2020) -
Xanthone-1,2,4-triazine and Acridone-1,2,4-triazine Conjugates: Synthesis and Anticancer Activity
por: Santra, Sougata, et al.
Publicado: (2023) -
Progress in Structure Based Drug Design for G Protein-Coupled Receptors
por: Congreve, Miles, et al.
Publicado: (2011)